Nasdaq · CIK 0001772177
KRUS KURA SUSHI USA, INC.
Insider trading from SEC Form 4. Last filing Feb 4, 2026. Close $40.53 on Oct 9, 2026, +17% from the 52-week low and -49% from the high.
KURA SUSHI USA, INC. (KRUS) has 31 SEC Form 4 filings on file from 12 insiders, the latest filed on Feb 4, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
2 open-market trades have been scored at KRUS. The newest: Hajime Uba (SEE REMARKS (a)) sold $720k of stock on Jan 16, 2026, filed Jan 21, 2026, scored 21 (weak), under a 10b5-1 plan.
KRUS closed at $40.53 on Oct 9, 2026, 17% above its 52-week low and 49% below its 52-week high.
1 Form 144 notice of planned sales is on file, the latest filed Jan 16, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at KURA SUSHI USA, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | Hajime Uba SEE REMARKS (a) sell | $720k 9,874 shares | -62% | +82% from low-21% from high | |
| 39Weak | Seitaro Ishii director sell | $574k 6,918 shares | -84% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 16, 2025 | ISHII SEITARO Director | 6,918 0.06% of outstanding | $576k | Jan 16, 2025 | none |
Transactions
The newest 50 of 64 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | Shahin Allameh Chief Operating Officer | FTax withholding Class A Common Stock | -126 | $69.29 | $8,731 | 4,086 | Feb 4, 2026 |
| Feb 3, 2026 | Hajime Uba SEE REMARKS (a) | FTax withholding Class A Common Stock | -255 | $69.29 | $18k | 9,777 | Feb 4, 2026 |
| Feb 3, 2026 | Robert Kluger Chief Development Officer | FTax withholding Class A Common Stock | -105 | $69.29 | $7,276 | 3,412 | Feb 4, 2026 |
| Feb 3, 2026 | Arlene Petokas Chief People Officer | FTax withholding Class A Common Stock | -101 | $69.29 | $7,019 | 4,686 | Feb 4, 2026 |
| Feb 3, 2026 | Brent Takao See Remarks | FTax withholding Class A Common Stock | -93 | $69.29 | $6,420 | 3,557 | Feb 4, 2026 |
| Feb 3, 2026 | Jeffrey J Uttz See Remarks | FTax withholding Class A Common Stock | -162 | $69.29 | $11k | 7,473 | Feb 4, 2026 |
| Feb 2, 2026 | Shintaro Asako director | AGrant or award Class A Common Stock | +1,047 | $0.00 | $0 | 3,235 | Feb 3, 2026 |
| Feb 1, 2026 | Shahin Allameh Chief Operating Officer | FTax withholding Class A Common Stock | -125 | $66.81 | $8,336 | 2,117 | Feb 3, 2026 |
| Feb 1, 2026 | Robert Kluger Chief Development Officer | FTax withholding Class A Common Stock | -107 | $66.81 | $7,126 | 1,777 | Feb 3, 2026 |
| Feb 1, 2026 | Arlene Petokas Chief People Officer | FTax withholding Class A Common Stock | -103 | $66.81 | $6,851 | 3,216 | Feb 3, 2026 |
| Feb 2, 2026 | Treasa Bowers director | AGrant or award Class A Common Stock | +1,047 | $0.00 | $0 | 2,392 | Feb 3, 2026 |
| Feb 1, 2026 | Jeffrey J Uttz See Remarks | FTax withholding Class A Common Stock | -163 | $66.81 | $11k | 5,121 | Feb 3, 2026 |
| Feb 1, 2026 | Hajime Uba SEE REMARKS (a) | FTax withholding Class A Common Stock | -223 | $66.81 | $15k | 5,804 | Feb 3, 2026 |
| Feb 2, 2026 | Carin Stutz director | AGrant or award Class A Common Stock | +1,047 | $0.00 | $0 | 5,085 | Feb 3, 2026 |
| Feb 2, 2026 | Claudia Schaefer director | AGrant or award Class A Common Stock | +1,078 | $0.00 | $0 | 1,078 | Feb 3, 2026 |
| Feb 1, 2026 | Brent Takao See Remarks | FTax withholding Class A Common Stock | -89 | $66.81 | $5,970 | 2,287 | Feb 3, 2026 |
| Feb 2, 2026 | Jeffrey J Uttz See Remarks | AGrant or award Class A Common Stock | +2,514 | $0.00 | $0 | 7,635 | Feb 3, 2026 |
| Feb 2, 2026 | Hajime Uba SEE REMARKS (a) | AGrant or award Class A Common Stock | +4,228 | $0.00 | $0 | 10,032 | Feb 3, 2026 |
| Feb 2, 2026 | Brent Takao See Remarks | AGrant or award Class A Common Stock | +1,362 | $0.00 | $0 | 3,649 | Feb 3, 2026 |
| Feb 2, 2026 | Robert Kluger Chief Development Officer | AGrant or award Class A Common Stock | +1,740 | $0.00 | $0 | 3,517 | Feb 3, 2026 |
| Feb 2, 2026 | Arlene Petokas Chief People Officer | AGrant or award Class A Common Stock | +1,571 | $0.00 | $0 | 4,787 | Feb 3, 2026 |
| Feb 2, 2026 | Claudia Schaefer director | AGrant or award Option to Purchase Class A Common Stockderivative | +2,000 | $0.00 | $0 | 2,000 | Feb 3, 2026 |
| Feb 2, 2026 | Shahin Allameh Chief Operating Officer | AGrant or award Class A Common Stock | +2,095 | $0.00 | $0 | 4,212 | Feb 3, 2026 |
| Jan 16, 2026 | Hajime Uba SEE REMARKS (a) | MOption exercise Class A Common Stock10b5-1 | +2,712 | $25.94 | $70k | 8,738 | Jan 21, 2026 |
| Jan 16, 2026 | Hajime Uba SEE REMARKS (a) | MOption exercise Class A Common Stock10b5-1 | -2,747 | $22.65 | $62k | 11,485 | Jan 21, 2026 |
| Jan 16, 2026 | Hajime Uba SEE REMARKS (a) | MOption exercise Class A Common Stock10b5-1 | -4,415 | $46.15 | $204k | 15,900 | Jan 21, 2026 |
| Jan 16, 2026 | Hajime Uba SEE REMARKS (a) | SOpen-market sale Class A Common Stock10b5-1 | -3,211 | $71.83 | $231k | 12,689 | Jan 21, 2026 |
| Jan 16, 2026 | Hajime Uba SEE REMARKS (a) | SOpen-market sale Class A Common Stock10b5-1 | -3,813 | $72.82 | $278k | 8,876 | Jan 21, 2026 |
| Jan 16, 2026 | Hajime Uba SEE REMARKS (a) | SOpen-market sale Class A Common Stock10b5-1 | -2,850 | $74.31 | $212k | 6,026 | Jan 21, 2026 |
| Jan 16, 2026 | Hajime Uba SEE REMARKS (a) | MOption exercise Option to Purchase Class A Common Stockderivative10b5-1 | -2,712 | $0.00 | $0 | 1,917 | Jan 21, 2026 |
| Jan 16, 2026 | Hajime Uba SEE REMARKS (a) | MOption exercise Option to Purchase Class A Common Stockderivative10b5-1 | -2,747 | $0.00 | $0 | 7,973 | Jan 21, 2026 |
| Jan 16, 2026 | Hajime Uba SEE REMARKS (a) | MOption exercise Option to Purchase Class A Common Stockderivative10b5-1 | -4,415 | $0.00 | $0 | 2,733 | Jan 21, 2026 |
| Aug 1, 2025 | Hajime Uba SEE REMARKS (a) | FTax withholding Class A Common Stock | -306 | $87.74 | $27k | 6,026 | Aug 5, 2025 |
| Aug 1, 2025 | Brent Takao See Remarks | FTax withholding Class A Common Stock | -214 | $87.74 | $19k | 2,377 | Aug 5, 2025 |
| Aug 1, 2025 | Jeffrey J Uttz See Remarks | FTax withholding Class A Common Stock | -252 | $87.74 | $22k | 5,284 | Aug 5, 2025 |
| Feb 3, 2025 | Shahin Allameh Chief Operating Officer | AGrant or award Class A Common Stock | +1,226 | $0.00 | $0 | 2,366 | Feb 5, 2025 |
| Feb 3, 2025 | Shintaro Asako director | AGrant or award Class A Common Stock | +875 | $0.00 | $0 | 2,188 | Feb 5, 2025 |
| Feb 3, 2025 | Treasa Bowers director | AGrant or award Class A Common Stock | +875 | $0.00 | $0 | 1,345 | Feb 5, 2025 |
| Feb 3, 2025 | Kim Ellis director | AGrant or award Class A Common Stock | +875 | $0.00 | $0 | 2,188 | Feb 5, 2025 |
| Feb 3, 2025 | Robert Kluger Chief Development Officer | AGrant or award Class A Common Stock | +1,020 | $0.00 | $0 | 1,990 | Feb 5, 2025 |
| Feb 3, 2025 | Jeffrey J Uttz See Remarks | AGrant or award Class A Common Stock | +1,750 | $0.00 | $0 | 5,700 | Feb 5, 2025 |
| Feb 3, 2025 | Brent Takao See Remarks (a) | AGrant or award Class A Common Stock | +900 | $0.00 | $0 | 2,680 | Feb 5, 2025 |
| Feb 3, 2025 | Carin Stutz director | AGrant or award Class A Common Stock | +875 | $0.00 | $0 | 4,038 | Feb 5, 2025 |
| Feb 3, 2025 | Hajime Uba SEE REMARKS (a) | AGrant or award Class A Common Stock | +2,842 | $0.00 | $0 | 6,587 | Feb 5, 2025 |
| Feb 3, 2025 | Arlene Petokas Chief People Officer | AGrant or award Class A Common Stock | +986 | $0.00 | $0 | 3,421 | Feb 5, 2025 |
| Feb 3, 2025 | Shahin Allameh Chief Operating Officer | FTax withholding Class A Common Stock | -53 | $80.00 | $4,207 | 2,313 | Feb 5, 2025 |
| Feb 3, 2025 | Robert Kluger Chief Development Officer | FTax withholding Class A Common Stock | -45 | $80.00 | $3,582 | 1,945 | Feb 5, 2025 |
| Feb 3, 2025 | Jeffrey J Uttz See Remarks | FTax withholding Class A Common Stock | -95 | $80.00 | $7,561 | 5,605 | Feb 5, 2025 |
| Feb 3, 2025 | Hajime Uba SEE REMARKS (a) | FTax withholding Class A Common Stock | -118 | $80.00 | $9,432 | 6,469 | Feb 5, 2025 |
| Feb 3, 2025 | Arlene Petokas Chief People Officer | FTax withholding Class A Common Stock | -43 | $80.00 | $3,451 | 3,378 | Feb 5, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Shahin AllamehChief Operating Officer
- Shintaro Asakodirector
- Treasa Bowersdirector
- Kim Ellisdirector
- Seitaro Ishiidirector
- Robert KlugerChief Development Officer
- Arlene PetokasChief People Officer
- Carin Stutzdirector
- Claudia Schaeferdirector
- Brent TakaoSee Remarks
- Hajime UbaSEE REMARKS (a)
- Jeffrey J UttzSee Remarks
Questions about KRUS
Answered from the filings on this page, as of the latest one.
Are insiders buying KRUS?
No. In the last 90 days no insider at KURA SUSHI USA, INC. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade KRUS on the open market?
Hajime Uba (SEE REMARKS (a)) sold $720k of KRUS on Jan 16, 2026 and filed the Form 4 on Jan 21, 2026. InsiderTell scored 21 (weak), under a 10b5-1 plan.
How many insiders file Form 4 at KURA SUSHI USA, INC.?
12 people have filed a Form 4 at KURA SUSHI USA, INC., among them Shahin Allameh (Chief Operating Officer), Shintaro Asako (director), Treasa Bowers (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.